 |
|
All placebos not created alike
February 01, 2006The debate about the existence of a placebo effect has heated up over the past year as more and more lab experiments are detecting immediate physiological responses to placebos. A new study takes placebo investigations out of the lab and into a clinical trial, showing a discernible placebo effect over time, according to an article in the Feb. 1 British Medical Journal.
While researchers usually use placebos in clinical trials to test the effectiveness of a new treatment, this trial pitted one placebo against another. "It's upside down research," said Ted Kaptchuk, assistant professor of medicine and associate director of the Division for Research and Education in Complementary and Integrative Medical Therapies and the Osher Institute at Harvard Medical School. "We investigated whether a sham acupuncture device has a greater placebo effect than an inert pill."
The study of 270 individuals with chronic arm pain had two phases. In the first phase, 135 patients were given sham acupuncture, and another 135 patients were given a placebo pill for two weeks. During this period, investigators found no strong evidence for an enhanced effect with placebo devices compared with placebo pills.
In the second phase of the study, the same patients were randomized again, with half the patients entered in a sham acupuncture device versus real acupuncture trial, and the other half in a placebo pill vs. real pain pill trial. The acupuncture trial extended four more weeks (the length believed needed to see improvement), and the pill trial lasted six more weeks (the length needed to have the real drug in the bloodstream).
In the second phase of the study, patients receiving sham acupuncture reported a more significant decrease in pain and symptom severity than those receiving placebo pills for the duration of the trials. The results of this study show that the placebo effect varies by type of placebo used.
"These findings suggest that the medical ritual of a device can deliver an enhanced placebo effect beyond that of a placebo pill. There are many conditions in which ritual is irrelevant when compared with drugs, such as in treatment of a bacterial infection," said Kaptchuk, "but the other extreme may also be true. In some cases, the ritual may be the critical component."
The enhanced placebo effect illustrated in this study applied only to subjective reports from patients about their perception of pain and the severity of their condition. More objective measures of grip strength showed no difference in improvements between the two placebos.
The results also provided evidence that what doctors tell patients about side effects directly influences their experience of them. Prior to participating in the study, doctors provided informed consent forms alerting the patients as to the side effects they might experience: temporary soreness for acupuncture and fatigue and dry-mouth for the pills. Of those receiving placebos, 25 percent of sham acupuncture and 31 percent of placebo pill patients reported experiencing the very side effects suggested to them even when nothing was administered to cause them.
This study takes the first step away from examining the placebo effect as a generalized phenomenon to one investigating how it varies in specific clinical environments. Kaptchuk and his colleagues have initiated other National Institute of Health funded studies that will explore the placebo phenomenon in clinical trials for different illnesses and in laboratory experiments that focus on underlying neurobiological, biochemical, genetic and psychological mechanisms.
Though the results of this study add evidence pointing to the existence of a placebo effect in a clinical environment, Kaptchuk does not recommend the use of placebos with patients or deception in the doctor-patient encounter. The aim is to understand how the ritual of healing affects health outcomes.
Harvard Medical School
In the second phase of the study, the same patients were randomized again, with half the patients entered in a sham acupuncture device versus real acupuncture trial, and the other half in a placebo pill vs. real pain pill trial. The acupuncture trial extended four more weeks (the length believed needed to see improvement), and the pill trial lasted six more weeks (the length needed to have the real drug in the bloodstream).
In the second phase of the study, patients receiving sham acupuncture reported a more significant decrease in pain and symptom severity than those receiving placebo pills for the duration of the trials. The results of this study show that the placebo effect varies by type of placebo used.
"These findings suggest that the medical ritual of a device can deliver an enhanced placebo effect beyond that of a placebo pill. There are many conditions in which ritual is irrelevant when compared with drugs, such as in treatment of a bacterial infection," said Kaptchuk, "but the other extreme may also be true. In some cases, the ritual may be the critical component."
The enhanced placebo effect illustrated in this study applied only to subjective reports from patients about their perception of pain and the severity of their condition. More objective measures of grip strength showed no difference in improvements between the two placebos.
The results also provided evidence that what doctors tell patients about side effects directly influences their experience of them. Prior to participating in the study, doctors provided informed consent forms alerting the patients as to the side effects they might experience: temporary soreness for acupuncture and fatigue and dry-mouth for the pills. Of those receiving placebos, 25 percent of sham acupuncture and 31 percent of placebo pill patients reported experiencing the very side effects suggested to them even when nothing was administered to cause them.
This study takes the first step away from examining the placebo effect as a generalized phenomenon to one investigating how it varies in specific clinical environments. Kaptchuk and his colleagues have initiated other National Institute of Health funded studies that will explore the placebo phenomenon in clinical trials for different illnesses and in laboratory experiments that focus on underlying neurobiological, biochemical, genetic and psychological mechanisms.
Though the results of this study add evidence pointing to the existence of a placebo effect in a clinical environment, Kaptchuk does not recommend the use of placebos with patients or deception in the doctor-patient encounter. The aim is to understand how the ritual of healing affects health outcomes.
Harvard Medical School
Placebo Current Events and Placebo News RSSDrug for erectile dysfunction improves heart function in young heart-disease patients
Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia.
Pivotal study for PSD502 -- the first potential treatment for premature ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
Your Own Stem Cells Can Treat Heart Disease
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells.
Viagra for women? Drug developed as antidepressant effective in treating low libido
Pooled results from three separate clinical trials of flibanserin, a drug originally created as an antidepressant, show it is effective in treating women with acquired hypoactive sexual desire disorder. These trials were the first ever to test a therapy that works at the level of the brain to enhance libido in women reporting low sexual desire.
Despite some benefit, drug ads can be harmful to your health
While the debate over prescription drug advertising persists, a new study released online in the American Journal of Public Health offers guidelines for improving drug ads in order to minimize potential harm and maximize benefits.
The narrow line between love and jealousy
A new study carried out at the University of Haifa has found that the hormone oxytocin, the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating.
CSHL study shows that some malignant tumors can be shut down after all
Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53.
Does green tea prevent cancer? Evidence continues to brew, but questions remain
Although scientists are reluctant to officially endorse green tea as a cancer prevention method, evidence continues to grow about its protective effects, including results of a new study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, which suggests some reduction in oral cancer.
Green tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds
Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Java and nighttime jobs don't mix: study
Night-shift workers should avoid drinking coffee if they wish to improve their sleep, according to research published in the journal Sleep Medicine.
More Placebo Current Events and Placebo News Articles
 |
Battle for the Sun by Placebo 2009 release, the sixth studio album from the British Alt-Rock trio. With a 13 year history that takes in five studio albums, 10 million album sales, breakdowns, clean ups and the dizzy swell of global success, Placebo return with their first album since the release of Meds in 2006. Battle For The Sun was recorded over three months by producer Dave Bottrill (chosen by the band largely because of his work with Tool) in his Toronto studio and mixed in London by Alan Moulder. Battle For The Sun is a startling, alive, vital and boundary-vaulting record that marks a whole new era for a band that were in need of a change. |
 |
Meds by Placebo |
 |
Running Up That Hill (2007 Digital Remaster) Placebo (Primary Contributor) |
 |
Without You I'm Nothing by Placebo This U.K. three-piece's self-titled debut often got compared to Smashing Pumpkins and Rush--Smashing Pumpkins for its unashamed mid-'70s prog-rock allusions and Rush because of singer Brian Molko's unusually high-pitched, almost androgynous voice. In reality, Placebo were far more salacious, downright dirty, and culturally confusing than either. (The band is a mix of American, Swedish, and English, with some Lebanese and Luxembourgian thrown in.) For their second album, Placebo have looked to the late '70s for inspiration, to the sound of early New Order and the Banshees--with a dash of the '90s thrown in: "Brick Shithouse," for example, starts like the most balls-out Prodigy song. If their debut was the sound of a no-holds-barred sexual drug frenzy lasting way into the next day, then... |
 |
Sleeping with Ghosts by Placebo This is the fourth album from Placebo & the follow up to 'Black Market Music', which was released in 2000. With help from Jim Abbiss (Massive Attack, Bjork & UNCLE), 'Sleeping With Ghosts' sees the band moving into a more experimental, electronic territor |
 |
Battle For The Sun (Amazon MP3 Exclusive Version) Placebo (Primary Contributor) |
 |
Once More with Feeling: Singles 1996-2004 by Placebo |
 |
Battle for the Sun (Limited Edition) (Incl. Bonus DVD) by Placebo Exclusive two disc (CD + NTSC/Region 0 DVD) edition includes one bonus track (the Chinese mix of 'Post Blue' featuring Chinese vocalist Li Ya) plus a bonus DVD containing the 20-minute "making of Battle For The Sun" featurette and the 'For What It's Worth' music video. 2009 release, the sixth studio album from the British Alt-Rock trio. With a 13 year history that takes in five studio albums, 10 million album sales, breakdowns, clean ups and the dizzy swell of global success, Placebo return with their first album since the release of Meds in 2006. Battle For The Sun was recorded over three months by producer Dave Bottrill (chosen by the band largely because of his work with Tool) in his Toronto studio and mixed in London by Alan Moulder. Battle For The Sun is a startling, alive, vital and... |
![Pure Morning (Album Version) [Explicit]](http://ecx.images-amazon.com/images/I/51ubN1wXqhL._SL160_.jpg) |
Pure Morning (Album Version) [Explicit] Placebo (Primary Contributor) |
 |
Soulmates Never Die: Live in Paris 2003 Starring: Placebo |
| © 2009 BrightSurf.com |